Complete your diagnosis Logo  Medicines
Go to Stage IV (Metastatic) NSCLC
Go to Early-Stage (Resectable) NSCLC
  • Go to Stage IV (Metastatic) NSCLC
  • Go to Early-Stage (Resectable) NSCLC
Complete your diagnosis LogoComplete your diagnosis Logo
  • CYD
  • More Hide

    background

    You are leaving completeyourdiagnosis.com

    This link will take you to a site maintained by a third party who is solely responsible for its content.

    AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

    Cancel Continue

    You are leaving You are leaving completeyourdiagnosis.com

    Links to the external websites are provided as a convinence to the viewer.

    AstraZeneca accepts no responsibility for the content of external sites

    Cancel Ok

    Have You Completed YourNon-Small Cell Lung Cancer Diagnosis?

    If you’ve been diagnosed with non-small cell lung cancer (NSCLC), comprehensive biomarker testing could help provide you and your doctor with a deeper understanding of your specific type of lung cancer and may help determine your path forward for treatment.

    There’s one more step to complete your diagnosis.

    Choose your NSCLC stage below to explore your next step.

      • I have been diagnosed with EARLY STAGE (RESECTABLE) NSCLC
      • LEARN MORE
      • I have been diagnosed with STAGE IV (METASTATIC) NSCLC
      • LEARN MORE

    You are leaving completeyourdiagnosis.com

    This link will take you to a site maintained by a third party who is solely responsible for its content.

    AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

    Cancel Continue

    You are leaving You are leaving completeyourdiagnosis.com

    Links to the external websites are provided as a convinence to the viewer.

    AstraZeneca accepts no responsibility for the content of external sites

    Cancel Ok

    AstraZeneca Medicines

    NCCN Guidelines for Patients for Non-Small Cell Lung Cancer - Early and Locally Advanced, 2022. ©2022 National Comprehensive Cancer Network, All Rights Reserved. Accessed September 21, 2022. To view the most recent and complete version of the NCCN Guidelines for Patients, visit NCCN.org/patientguidelines.

    NCCN Guidelines for Patients for Non-Small Cell Lung Cancer - Metastatic, 2022. ©2022 National Comprehensive Cancer Network, All Rights Reserved. Accessed September 21, 2022. To view the most recent and complete version of the NCCN Guidelines for Patients, visit NCCN.org/patientguidelines.

    Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer V.5.2022. ©National Comprehensive Cancer Network, Inc. 2022. All rights reserved. Accessed September 21, 2022. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

    The information on this website is provided by AstraZeneca for educational purposes only and should not take the place of talking with your doctor or healthcare professional. It should not be used for diagnosing or treating a health problem or disease. If you have any questions about your medical condition, talk to your doctor or pharmacist.

    This information is intended for US consumers only.


    • Privacy Notice
    • Cookie Preferences
    • Legal Terms and Conditions
    • Contact Us
    • Your Privacy Choices
    • Consumer Health Data Privacy Notice
    AstraZeneca logo
    AstraZeneca logo

    ©2022 AstraZeneca. All rights reserved. US-63647 Last Updated 11/22

     

    Loading......

    Expiry Date : January,2025
    Back to top